Stifel Financial’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $972K | Sell |
16,718
-830
| -5% | -$38.2K | ﹤0.01% | 2472 |
|
|
2025
Q4 | $787K | Sell |
17,548
-1,167
| -6% | -$49K | ﹤0.01% | 2583 |
|
|
2025
Q3 | $751K | Sell |
18,715
-1,907
| -9% | -$67.2K | ﹤0.01% | 2566 |
|
|
2025
Q2 | $645K | Buy |
20,622
+95
| +0.5% | +$3.1K | ﹤0.01% | 2611 |
|
|
2025
Q1 | $689K | Sell |
20,527
-161
| -0.8% | -$6.11K | ﹤0.01% | 2468 |
|
|
2024
Q4 | $811K | Sell |
20,688
-883
| -4% | -$36.5K | ﹤0.01% | 2386 |
|
|
2024
Q3 | $849K | Sell |
21,571
-512
| -2% | -$20.6K | ﹤0.01% | 2340 |
|
|
2024
Q2 | $861K | Sell |
22,083
-92
| -0.4% | -$3.68K | ﹤0.01% | 2262 |
|
|
2024
Q1 | $955K | Buy |
22,175
+1,294
| +6% | +$59.5K | ﹤0.01% | 2213 |
|
|
2023
Q4 | $962K | Buy |
20,881
+401
| +2% | +$14.2K | ﹤0.01% | 2169 |
|
|
2023
Q3 | $700K | Buy |
20,480
+399
| +2% | +$14.9K | ﹤0.01% | 2294 |
|
|
2023
Q2 | $773K | Buy |
20,081
+9,777
| +95% | +$389K | ﹤0.01% | 2244 |
|
|
2023
Q1 | $369K | Buy |
10,304
+360
| +4% | +$13.3K | ﹤0.01% | 2686 |
|
|
2022
Q4 | $392K | Sell |
9,944
-100
| -1% | -$3.64K | ﹤0.01% | 2611 |
|
|
2022
Q3 | $363K | Hold |
10,044
| – | – | ﹤0.01% | 2626 |
|
|
2022
Q2 | $306K | Sell |
10,044
-823
| -8% | -$24.9K | ﹤0.01% | 2738 |
|
|
2022
Q1 | $332K | Sell |
10,867
-617
| -5% | -$18.5K | ﹤0.01% | 2815 |
|
|
2021
Q4 | $358K | Buy |
11,484
+556
| +5% | +$16.6K | ﹤0.01% | 2804 |
|
|
2021
Q3 | $167K | Buy |
+10,928
| New | +$190K | ﹤0.01% | 3163 |
|
|
2018
Q3 | – | Sell |
-11,500
| Closed | -$106K | – | 2828 |
|
|
2018
Q2 | $106K | Sell |
11,500
-375
| -3% | -$2.33K | ﹤0.01% | 2629 |
|
|
2018
Q1 | $58K | Sell |
11,875
-10,325
| -47% | -$38.2K | ﹤0.01% | 2614 |
|
|
2017
Q4 | $63K | Buy |
22,200
+500
| +2% | +$1.36K | ﹤0.01% | 2580 |
|
|
2017
Q3 | $65K | Buy |
+21,700
| New | +$67.1K | ﹤0.01% | 2504 |
|
Other funds holding XENE
ACA
DCM
PCH
